$SGMOQ SEC Filings

Filed On	Filing
27 Oct 2026	8-K: Regulation FD Disclosure Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
16 Oct 2026	8-K: Regulation FD Disclosure Debtor’s Full-Time Employees (as of date of order for relief):
07 Oct 2026	25-NSE
21 Sep 2026	8-K: Bankruptcy or Receivership; Completion of Acquisition or Disposition of Assets The information set forth under Item 2.01 below is incorporated into this Item 1.03 by reference.
08 Sep 2026	8-K: Bankruptcy or Receivership; Completion of Acquisition or Disposition of Assets +1 more UST Form 11-MOR (12/01/2021) 1 UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE In Re. SANGAMO THERAPEUTICS, INC. Debtor(s) § § § § Case No. 26-10989 Jointly Administered Monthly Operating Report Chapter 11 Reporting Period Ended: 07/...
28 Aug 2026	8-K: Entry into a Material Definitive Agreement; Bankruptcy or Receivership
17 Aug 2026	NT 10-Q
14 Aug 2026	SCHEDULE 13G/A
13 Aug 2026	8-K: Other Events
12 Aug 2026	8-K: Regulation FD Disclosure
20 Jul 2026	8-K: Bankruptcy or Receivership; Notice of Delisting or Failure to Satisfy a Listing Rule
01 Jul 2026	8-K: Changes in Registrant's Certifying Accountant; Other Events
23 Jun 2026	8-K/A: Financial Statements and Exhibits This Asset Purchase Agreement, dated as of June 22, 2026 (this “Agreement”), is made by and among (i) Sangamo Therapeutics, Inc., a Delaware corporation (“Seller”), (ii) Merope Acquisition Sub, LLC, a Delaware limited liability company a...
23 Jun 2026	8-K: Entry into a Material Definitive Agreement; Bankruptcy or Receivership +2 more
27 May 2026	Form 4: Davis Gregory D, Head of Research & Technology Gave up 1,630 shares to cover exercise price or tax ($284)
27 May 2026	Form 4: Jain Nikunj, Principal Accounting Officer Gave up 1,919 shares to cover exercise price or tax ($334)
27 May 2026	Form 4: Dubois-Stringfellow Nathalie, SVP-CHIEF DEVELOPMENT OFFICER Gave up 4,036 shares to cover exercise price or tax ($703)
27 May 2026	Form 4: Willoughby Scott B., SVP, CHIEF LEGAL OFFICER, SECY Gave up 4,036 shares to cover exercise price or tax ($703)
27 May 2026	Form 4: Macrae Sandy, Director Gave up 12,613 shares to cover exercise price or tax ($2.2K)
15 May 2026	SCHEDULE 13G

Comments